GLAND PHARMA LIMITED
Key Quantitative Figures
- IGST Demand Amount: INR 3,52,93,678
- Penalty Levied: INR 3,52,93,678
- Total Disputed Amount (Demand + Penalty): INR 7,05,87,356
- Applicable Interest: Applicable interest on the IGST demand is also confirmed, though the exact amount is not quantified in the disclosure.
Dates of Action
- Order Issuance Date: July 10, 2026
- Order Number: HYD-CUS-004-COM-26-27
- Order Receipt Date: July 15, 2026 (received via Speed Post)
- Disclosure Date: July 16, 2026
Parties Involved
- Issuing Authority: Principal Commissioner of Customs, Office of the Principal Commissioner of Customs, Customs Department, Hyderabad, Telangana.
- Recipient Entity: Gland Pharma Limited.
Purpose and Details of the Order
The Order-in-Original was passed by the Customs Authority concerning the availment of IGST benefits under Notification No. 18/2015-Cus. The order confirms a demand for IGST of INR 3.53 crore for the financial years 2020-2021 and 2021-2022, along with applicable interest. It also levies a penalty of an equal amount (INR 3.53 crore) under the applicable provisions of the Customs Act, 1962.
Company's Response and Financial Impact
The company is in the process of filing a necessary appeal with the appellate authority. Based on its evaluation of the facts and prevailing law, the company is of the view that the IGST demand and penalties are not justified. The disclosure explicitly states: "Based on our evaluation there is no material impact on the financials, operations, or other activities of the Company due to the said order."